Shares in Fever-Tree have increased by over 5% after the drinks company reiterated its guidance for the current financial year in its latest AGM update.

The firm said that it has made a “solid start to the year”, and has continued to execute against its strategic priorities.

These include establishing the platform to accelerate growth in the US following its partnership with Molson Coors; the continuation of its diversification strategy; continued category leadership with further share gains across key markets; and the building of business resilience.

As part of its AGM update, the Fever-Tree board announced a £30m extension to its share buyback programme, building on its £100m share buyback completed in FY25 and the ongoing £30m tranche, of which £18.9m has been returned as of 5 June.

CEO at Fever-Tree, Tim Warrillow, stated: "We have continued to make good progress against our strategic priorities so far this year. Fever-Tree is well placed to drive long-term growth across our markets as both a premium mixer and soft drink brand and this year we are significantly increasing marketing investment and innovating to support our growth ambitions.

"Notwithstanding the current uncertainty in the geopolitical backdrop, we are well hedged from a cost perspective and remain confident in achieving market expectations for both adjusted revenue and EBITDA."

---